135 related articles for article (PubMed ID: 1534589)
21. U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis.
Long MW; Snider DE; Farer LS
Am Rev Respir Dis; 1979 Jun; 119(6):879-94. PubMed ID: 110184
[TBL] [Abstract][Full Text] [Related]
22. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
23. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
24. [Therapeutic approach in a case of allergic reaction to antituberculosis drugs -- a case report].
Costin M; Tesloianu A; Mihăescu T; Butnaru E
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):487-9. PubMed ID: 23077942
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days.
Jindani A; Doré CJ; Mitchison DA
Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740
[TBL] [Abstract][Full Text] [Related]
26. [Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid].
Nagayama N; Shishido Y; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
Kekkaku; 2004 May; 79(5):341-8. PubMed ID: 15211874
[TBL] [Abstract][Full Text] [Related]
27. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate.
Umeki S
Jpn J Med; 1989; 28(3):335-40. PubMed ID: 2739142
[TBL] [Abstract][Full Text] [Related]
28. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
González Montaner LJ; Palma Beltrán O; Abbate E; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
[No Abstract] [Full Text] [Related]
29. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
30. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
Özkaya E
Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
[TBL] [Abstract][Full Text] [Related]
31. Ethambutol-isoniazid versus streptomycin-ethambutol-isoniazid in original treatment of cavitary tuberculosis.
Bobrowitz ID
Am Rev Respir Dis; 1974 May; 109(5):548-53. PubMed ID: 4207273
[No Abstract] [Full Text] [Related]
32. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
33. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
34. Side effects of rifampicin. A clinical study.
Mattson K
Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
[No Abstract] [Full Text] [Related]
35. Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
Tubercle; 1970 Jun; 51(2):123-51. PubMed ID: 4099678
[No Abstract] [Full Text] [Related]
36. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
Virsik K; Kruty R; Matula F; Badalik L
Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
[No Abstract] [Full Text] [Related]
37. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
[TBL] [Abstract][Full Text] [Related]
38. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
Kradolfer F; Schnell R
Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
[No Abstract] [Full Text] [Related]
39. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis].
Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H
Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720
[TBL] [Abstract][Full Text] [Related]
40. [The efficacy of the treatment of newly diagnosed patients with destructive tuberculosis of the lungs using rifampicin in combination with other drugs].
Roslik SM; Pashkov IuN; Gerasimova TG; Marveeva SL
Probl Tuberk; 1990; (5):75-6. PubMed ID: 2388900
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]